ETRAVIRINE
NDC 80005-112, ETRAVIRINE, tablet, from Carnegie Pharmaceuticals LLC.
- Product NDC
- 80005-112
- Status
- Listed
- Labeler
- Carnegie Pharmaceuticals LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215402
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/80005-112 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ETRAVIRINE100 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 80005-112-12 | 80005011212 | 120 TABLET in 1 BOTTLE (80005-112-12) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/154b621d-9a72-489f-9127-55f9bf1797a0
Use it
Look up 80005-112 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/80005-112 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 80005-112. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.